Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea.
Sclerosing encapsulating peritonitis (SEP) is a rare but serious complication in patients with continuous ambulatory peritoneal dialysis (CAPD), and is characterized by a progressive, intra-abdominal, inflammatory process resulting in the formation of sheets of new fibrous tissue, which cover, bind, and constrict the viscera, thereby compromising the motility of the bowel. No satisfactory estimate is available on the comparative incidence of dialysis related SEP and the pathogenesis of SEP still remains uncertain. Although recent therapeutic approaches have reported varying degrees of success, an efficient measure to detect, at an early stage, patients at risk for SEP would be beneficial and a standardized treatment regimen to prevent the illness is urgently needed. This study aimed to evaluate the clinical features of SEP and to identify the possible risk factors for the development of SEP in CAPD patients. We retrospectively reviewed by questionnaire SEP cases among CAPD patients from 7 university hospital dialysis centers in Korea, including Yonsei University, Ajou University, Catholic University, Inha University, Kyungpook University, Seoul National University and Soonchunhyang University, from January 1981 to December 2002. Out of a total of 4,290 CAPD patients in these centers, 34 cases developed SEP with an overall prevalence of 0.79%. The male to female ratio was 17:17. The median age of these patients was 44.5 years (range 19-66). The median duration of CAPD before SEP was 64 months (9-144) and 68% of patients (23/34) had been on CAPD for more than 4 years. Peritonitis (including two fungal cases) was the main cause of catheter removal in SEP (27 cases, 79%). Seventy-five percent of the cases (15/20) were administered beta-blocker for a mean duration of 85 months (26-130). Among 10 cases with available peritoneal equilibration test (PET) data, 8 showed high transporter characteristics, and the remaining 2 were high average. Eighteen cases were diagnosed by clinical and radiologic methods, and 16 were surgically diagnosed. Eleven cases were surgically treated and the others were treated conservatively with intermittent total parenteral nutrition (TPN). The overall mortality rate was 24%. SEP is a serious, life threatening complication of CAPD. Most cases had a PD duration of more than 4 years, a history of severe peritonitis, and high transporter characteristics in PET. Therefore, to reduce the incidence of SEP, careful monitoring and treatment, including early catheter removal in patients with severe peritonitis, should be considered for long-term CAPD patients with the above characteristics.
Kim
Beom Seok
BS
Division of Nephrology, Department of Internal Medicine, Institute of Kidney Disease, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul 120-752, Korea.
Choi
Hoon Young
HY
Ryu
Dong-Ryeol
DR
Yoo
Tae Hyun
TH
Park
Hyeong Cheon
HC
Kang
Shin Wook
SW
Choi
Kyu Hun
KH
Ha
Sung Kyu
SK
Han
Dae Suk
DS
Lee
Ho Yung
HY
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D015994:Incidence; D007723:Korea / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects* / Q000706:statistics & numerical data*; D010538:Peritonitis / Q000453:epidemiology* / Q000209:etiology / Q000473:pathology*; D015995:Prevalence; D012598:Sclerosis
J Nephrol. 1999 Nov-Dec;12(6):347-61
10626824
Am J Kidney Dis. 1996 Sep;28(3):420-7
8804242
Perit Dial Int. 2000;20 Suppl 4:S43-55
11098928
Br J Surg. 1977 Apr;64(4):229-35
856375
Br J Surg. 1977 Apr;64(4):255-7
851701
Arch Intern Med. 1980 Aug;140(8):1124-5
6446892
Arch Intern Med. 1980 Sep;140(9):1201-3
7406618
Acta Chir Scand. 1981;147(2):137-42
7324743
Proc Eur Dial Transplant Assoc. 1981;18:199-205
7329968
Br Med J (Clin Res Ed). 1982 Mar 20;284(6319):870
6802333
Lancet. 1983 Aug 13;2(8346):409
6135907
Am J Med. 1983 Aug;75(2):349-52
6881189
Am J Med. 1984 May;76(5):A113, A125
6720720
Am J Nephrol. 1984;4(3):173-6
6742010
AJR Am J Roentgenol. 1986 Nov;147(5):937-40
3532734
Nephron. 1987;45(3):229-32
3574572
Contrib Nephrol. 1987;57:239-47
2890497
Nephrol Dial Transplant. 1988;3(1):66-9
3132642
Blood Purif. 1989;7(2-3):95-108
2663040
Clin Radiol. 1990 Jan;41(1):19-23
2404649
Arch Surg. 1990 Dec;125(12):1626-8
2244819
Am J Kidney Dis. 1991 Jan;17(1):76-9
1986571
Perit Dial Int. 1992;12(1):14-27
1347465
Am J Kidney Dis. 1992 Dec;20(6):637-42
1462995
Adv Perit Dial. 1993;9:187-9
8105920
Isr J Med Sci. 1993 Nov;29(11):686-8
8270396
Am J Kidney Dis. 1994 Nov;24(5):819-25
7977325
Kidney Int Suppl. 1994 Dec;48:S79-86
7700046
ASAIO J. 1994 Jul-Sep;40(3):M892-5
8555641
Dig Dis Sci. 1996 Apr;41(4):684-8
8674388
Adv Ren Replace Ther. 1996 Jul;3(3):232-6
8827203
Nephrol Dial Transplant. 1997 Apr;12(4):821-2
9141024
Nephrol Dial Transplant. 1998 Jan;13(1):154-9
9481732
Blood Purif. 1998;16(1):1-14
9513757
Adv Ren Replace Ther. 1998 Jul;5(3):157-67
9686626
Dig Surg. 1998;15(6):697-702
9845640
Semin Dial. 2000 Sep-Oct;13(5):297-308
11014691